- Home
- IOVA vs INMD Comparison
IOVA vs INMD Comparison
Compare IOVA & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- INMD
- Stock Information
- Founded
- IOVA 2007
- INMD 2008
- Country
- IOVA United States
- INMD Israel
- Employees
- IOVA N/A
- INMD N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IOVA Health Care
- INMD Health Care
- Exchange
- IOVA Nasdaq
- INMD Nasdaq
- Market Cap
- IOVA 1.0B
- INMD 1.3B
- IPO Year
- IOVA N/A
- INMD 2019
- Fundamental
- Price
- IOVA $3.17
- INMD $14.23
- Analyst Decision
- IOVA Strong Buy
- INMD Hold
- Analyst Count
- IOVA 9
- INMD 6
- Target Price
- IOVA $18.22
- INMD $17.56
- AVG Volume (30 Days)
- IOVA 9.3M
- INMD 1.5M
- Earning Date
- IOVA 05-08-2025
- INMD 04-28-2025
- Dividend Yield
- IOVA N/A
- INMD N/A
- EPS Growth
- IOVA N/A
- INMD 8.69
- EPS
- IOVA N/A
- INMD 2.29
- Revenue
- IOVA $164,070,000.00
- INMD $392,408,000.00
- Revenue This Year
- IOVA $182.20
- INMD $1.63
- Revenue Next Year
- IOVA $62.10
- INMD $5.17
- P/E Ratio
- IOVA N/A
- INMD $6.24
- Revenue Growth
- IOVA 13698.99
- INMD N/A
- 52 Week Low
- IOVA $2.70
- INMD $13.68
- 52 Week High
- IOVA $13.60
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- IOVA 43.38
- INMD 38.86
- Support Level
- IOVA $3.02
- INMD $14.01
- Resistance Level
- IOVA $3.73
- INMD $15.12
- Average True Range (ATR)
- IOVA 0.25
- INMD 0.60
- MACD
- IOVA 0.01
- INMD 0.02
- Stochastic Oscillator
- IOVA 25.33
- INMD 16.29
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.